Action CLS B CLINICAL LASERTHERMIA SYSTEMS AB
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Clinical Laserthermia Systems AB

Actions

CLS B

SE0022049920

Temps Différé Nasdaq Stockholm
Autres places de cotation
 15:58:52 27/06/2024 		Varia. 5j. Varia. 1 janv.
5,701 SEK -4,94% Graphique intraday de Clinical Laserthermia Systems AB -6,06% -79,34%
25/06 Clinical Laserthermia Systems signe un accord de distribution en Italie pour la thérapie d'ablation au laser MT
25/06 Clinical Laserthermia Systems AB (publ) conclut un accord de distribution exclusive avec Tecnogamma S.r.l. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Clinical Laserthermia Systems Signs Italian Distribution Deal for Laser Ablation Therapy
CLS enters the Italian market for Focal Laser Ablation together with the Nationwide Italian Company Tecnogamma s.r.l.
Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with Tecnogamma S.r.l
Recruitment of Glioblastoma Patients to the CLS-sponsored Clinical Study at Skåne University Hospital is now Completed
Clinical Laserthermia Systems AB Announces Completion of Clinical Study At Skane University Hospital
Clinical Laserthermia Systems publishes supplementary prospectus regarding ongoing rights issue
CLS receives additional order for ClearPoint Prism products corresponding to approximately SEK 7.5 million
Clinical Laserthermia Systems AB Receives Additional Order for Clearpoint Prism Products Associated to Approximately SEK 7.5 Million
CLS publishes prospectus in connection with forthcoming rights issue
Clinical Laserthermia Systems publishes annual report for 2023
BioStock: CLS' partner initiates full market release in the US
First Clinical Data from the Investigator-initiated study with CLS Focal Laser Ablation system at the University Hospital Magdeburg will be presented at the Nordkongress in Lübeck 13-15 June 2024
CLS presents its new strategic direction in a Business Update Event on June 12
CLS Commercial Partner is Initiating Full Market Release of ClearPoint Prism 3T Neuro Laser Therapy System in The U.S
Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue
CLS resolves on a partially guaranteed Rights Issue of approximately SEK 59m
CLS publishes interim report January - March 2024
Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 28 2024
BioStock: CLS revises strategy - increases focus on neurosurgery
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action CLS B
  4. Actualités Clinical Laserthermia Systems AB
  5. Autres langues